2011
DOI: 10.1002/14651858.cd007615.pub3
|View full text |Cite
|
Sign up to set email alerts
|

Interventions for prevention of neonatal hyperglycemia in very low birth weight infants

Abstract: Glucose infusion rate: There is insufficient evidence from trials comparing lower with higher glucose infusion rates to inform clinical practice. Large randomized trials are needed, powered on clinical outcomes including death, major morbidities and adverse neurodevelopment.Insulin infusion: The evidence reviewed does not support the routine use of insulin infusions to prevent hyperglycemia in VLBW neonates. Further randomized trials of insulin infusion may be justified. They should enrol extremely low birth w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
24
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 58 publications
0
24
0
3
Order By: Relevance
“…First, inadequate glucose supply appears when there is insufficient enteral or parenteral nutritional input (5-7). Secondly, low glycogen stores may be a problem in preterm neonates, because glycogen starts to form in the 3rd trimester of pregnancy (2,5,7,17), and also in the case of in utero growth restriction (IUGR) (2,7,18). Thirdly, impaired glucose production is the result of metabolic disturbances of glycogenolysis, gluconeogenesis, amino acid, carbohydrate and fatty acid metabolism (19).…”
Section: Transient and Persistent Hypoglycaemiamentioning
confidence: 99%
See 2 more Smart Citations
“…First, inadequate glucose supply appears when there is insufficient enteral or parenteral nutritional input (5-7). Secondly, low glycogen stores may be a problem in preterm neonates, because glycogen starts to form in the 3rd trimester of pregnancy (2,5,7,17), and also in the case of in utero growth restriction (IUGR) (2,7,18). Thirdly, impaired glucose production is the result of metabolic disturbances of glycogenolysis, gluconeogenesis, amino acid, carbohydrate and fatty acid metabolism (19).…”
Section: Transient and Persistent Hypoglycaemiamentioning
confidence: 99%
“…Most often it is the consequence of unregulated maternal diabetes (type 1, type 2 or gestational) (25,26). Moreover, a transient increase in insulin concentration may be seen in some other conditions: in IUGR (7,18,27,28), after a stressful peripartum event (2,7,22,29), after maternal treatment with insulin or glucose during labour (30), and in the case of some foetal disorders: haemolytic disease of the newborn, hypothermia, heart failure (2, 7, 22) and in Beckwith-Wiedemann syndrome (BWS) (24,31,32).…”
Section: Transient and Persistent Hypoglycaemiamentioning
confidence: 99%
See 1 more Smart Citation
“…Se sugiere además que la glucemia no sobrepase los 150 mg/dL (GdE 5) (43) ya que se asocia con mayores complicaciones particularmente en los RNPT y/o de bajo peso al nacer. Es importante evitar el exceso de energía en forma de glucosa y administrar lípidos conjuntamente siempre que sea posible (sin olvidar que su contenido en glicerol es un sustrato neoglucogénico) (44).…”
Section: Requerimientos De Glucosaunclassified
“…En los RN no se recomienda el uso rutinario de insulina precozmente para evitar la hiperglucemia debido al riesgo elevado de hipoglucemia e incremento de mortalidad (43,44); solo se propone su administración en casos de hiperglucemia persistente cuando ya se han intentado evitar y/o regular sus causas (43). Se infundirá en perfusión continua conectada en "Y" a la NP o bien, se puede incluir en la bolsa de la NP (esta última posibilidad se contemplará en pacientes estables).…”
Section: Requerimientos De Glucosaunclassified